MaxLinear Q1 2026 Earnings EPS Beats Estimates Despite Revenue Uncertainty Iveda Solutions Q2 2024 Earnings EPS Surpasses Estimates Despite Minimal Revenue Data Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses MAXN Q4 2024 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid Solar Industry Headwinds SNTI Q1 2026 Earnings NarrowerThanExpected Loss Highlights Cost Discipline in PreRevenue Phase AZN Q1 2026 Earnings EPS Slightly Misses Estimates Amid Mixed Sentiment